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Introduction
Epilepsy is one of the most common neurological disorders in the world with more 
than 50 million affected. The incidence rate of epilepsy in the general population 
is 0.2–0.4%. Researchers have shown that in developing countries, 2–4% have 
recurrent epileptic attacks during their lifetime (1). However, because of the 
side effects and cultural issues due to antiepileptic drugs, some patients refuse 
to use antiepileptic drugs. Considering the high incidence of convulsions and the 
complications of uncontrolled seizures, it is a priority to control this disorder. The 
mortality and morbidity rates increase in recurrent cases (1). 
Abstract
Objective 
Epilepsy is a serious, potentially life-shortening brain disorder that occurs in 
patients of all ages and races. A total of 2–4% of people have experienced 
seizures at least once in their lifetime. Although treatment usually begins after 
a seizure, it is an important question whether the first cases of seizure do need 
to be treated by antiepileptic drugs. In this manner, we compare the recurrence 
rates of epilepsy in first seizure patients treated with sodium valproic acid as an 
antiepileptic drug versus a placebo. 
Material & Methods
In a randomized clinical trial study, 101 first seizure patients were randomly 
divided into two groups: one group was treated with antiepileptic drugs (sodium 
valproate 200mg, three times a day) and the other group was given a placebo. 
The recurrence rate of seizures was evaluated and compared between the groups 
after 6 months of follow up. 
Results
Eight recurrence cases were detected. All recurrence cases came from the placebo 
group, with four patients suffering an additional seizure after four months and 
between 4-6 month follow up. A comparison of recurrence rate detected a 
statistically significant difference between the drug group and placebo group.
Conclusion
Our data shows that the recurrences occurred only in the placebo group with 
the difference between the recurrence rates in the placebo versus drug-treated 
was significant. Our results suggest that drug therapy for people after their first 
seizure attack might reduce the probability of seizure recurrence. 
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significance of two unprovoked convulsions in one 
day is still unclear and considering these convulsions 
as a single simple seizure is controversial (16). In a 
quantitative review, the risk of seizure recurrence near 
two years following first attack was 36% and 47%, 
in prospective and retrospective studies, respectively 
(15). To avoid recurrence, the recommendation is to 
avoid provoking activities after first seizure for three 
months (17). Driving restrictions after the first seizure 
are controversial and most neurologists believe that 
patients should avoid driving for 3 months.
Antiepileptics are a class of drugs that suppress attacks 
of epilepsy or reduce their frequency and severity. 
Valproic acid, often called valproate, is one such 
antiepileptic with a double mechanism of action: it 
decreases the influx of sodium and increases that 
of chloride by indirect Gamma-Aminobutyric Acid 
(GABA) mimetic effect. By these two complementary 
mechanisms, valproic acid increases the polarization 
of the cell and decreases its excitability. Its GABA-
mimetic effect prevails on its effect on the voltage-
dependent sodium channels. It is effective in the 
majority of epilepsies and is widely used (5, 10, 12). 
The purpose of the current randomized clinical trial is 
to compare the recurrence rate of epilepsy in the first 
seizure patients treated with sodium valproate acid as an 
antiepileptic drug or placebo.
Material & Methods
Patients referred to the Neurology Clinic of Emam 
Hossein Medical and Educational Center (from 2009–
2011) with a first seizure were evaluated with inclusion 
and exclusion criteria. In all patients, the first seizure 
was generalized tonic-clonic form (GTC). If the patient 
had a family history of seizures, history of head trauma, 
tumors, meningitis, and neurological disorders, they 
were excluded. A thorough neurologic examination, 
electroencephalography (EEG), and a magnetic 
resonance imaging (MRI) were then performed. If all of 
the examinations, the EEG, and the MRI were normal 
and the patients had not taken any specific drugs, they 
were then included in the project.
Patients were randomly categorized into two groups. 
One group (n = 50) received sodium valproate 200 mg 
three times a day as an antiepileptic drug and the other 
There is controversy regarding treatment of first time 
seizure patients since they are not defined as having 
epilepsy after just one seizure. In order to make a decision 
in these cases, recurrence rates and the effectiveness of 
antiepileptic drugs need to be evaluated. First seizures 
are a terrifying experience. It has been shown that any 
person has a 8–10% chance of experiencing a seizure 
event and 3% chance of becoming epileptic (2). Most 
of the time, the cause of first seizure is a pathology 
in the central nervous system (CNS) after which the 
recurrence rate is 30–50%. This recurrence rate rises to 
70–80% after the second unprovoked seizure making 
the diagnosis of epilepsy more probable (3-7). 
First seizures have important differential diagnoses 
including syncope (breathing cessation and loss of 
consciousness), transient ischemic attacks (TIA), 
metabolic encephalopathy (hypoglycemia, electrolyte 
imbalances), nightmares, complex migraine, cardiac 
arrhythmia, and pseudoseizures. Convulsive syncope 
is a new topic and is defined when syncope induces 
seizures or death. Precise history taking is crucial 
for diagnosis but there is often no single diagnostic 
finding in patient histories. Investigations demonstrate 
that most patients with tonic-clonic seizures have had 
a previous simple or complex partial seizure (2, 8, 
9). About 25–30% of first seizures are symptomatic 
and provoked by a CNS pathology or electrolyte 
imbalances or metabolic disorders (10-13). Convulsion 
inducing factors are fever, head trauma, excessive 
alcohol consumption, withdrawal syndromes of alcohol 
or illicit drugs, cerebral infections, ischemic attacks, 
intracranial hemorrhage, and drugs, such as clozapine, 
maprotiline, tramadol, theophylline, and baclofen, after 
baclofen. Seizures induced by metabolic disorders or 
toxicities have a lower chance of becoming epilepsy 
(lower than 3%) but organic disorders like cerebral 
abscesses increase the chance to greater than 10%. 
Seizures occurring after physiological stresses are not 
categorized as “acute symptomatic” and are instead 
called “triggered seizures”. Laboratory data of complete 
blood test and urine and cerebrospinal fluid (CSF) 
analysis are needed to diagnose these patients (14). 
To avoid recurrent attacks, patients should be aware 
of inducing factors as the recurrence rate of a first 
seizure after two years is approximately 42% (15). The 
Antiepileptic Treatment in Recurrence Rate of Seizures
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University of Medical Sciences (SBMU), all patients 
signed a written informed consent form for this project.
Results
A total of 101 patients were included in this research 
with 50 patients receiving antiepileptic drugs (sodium 
valproate group) and 51 receiving a placebo (placebo 
group). Fifty-seven patients were male (56.9%) and 44 
were female (43.1%). The mean age of patients was 
34.7 ± 16.3. Patient educational status was divided into 
4 levels, 10 cases (9.9%) were illiterate, 22 (21.8%) with 
elementary education, 45 (44.6%) with diploma, and 
24 (23.7%) with masters or above. The mean duration 
of first seizure was 4.9 ± 4.2 minutes. There was not 
a significant difference in demographic characters 
between the two groups (p > 0.05) (Table 1).
Antiepileptic Treatment in Recurrence Rate of Seizures
group (n = 51) was given multivitamins as a placebo. 
Patients were followed for 6 months and evaluated 
for recurrence rate and drug side effects. Data were 
collected by filling in questionnaires and interviews. 
Regarding ethics, the patients in the placebo group 
were excluded if they experienced seizures during the 
follow up period and these patients received appropriate 
medicine. The data were analyzed using SPSS (v.19). 
Frequency tables and scattering parameters obtained 
using descriptive statistics and reported as mean ± SD. 
Qualitative variables were compared between the two 
groups using Chi-square test and quantitative variables 
analyzed by t-test. In this study, a significant level of p 
= 0.05 was considered.
In accordance with the Helsinki Declaration and 
the Medical Ethics Committee of Shahid Beheshti 








Age Mean ± SD 33.6 ± 9.4 36.9 ± 7.7 0.19
Gender
Male (n) 27 30
0.4
Female (n) 23 21
Educational status 
Illiterate (n) 5 5
0.28
Elementary (n) 10 12
Diploma (n) 24 21
Masters or above (n) 11 13
Duration of first seizure
(min)
Mean ± SD 5.2 ± 4.4 4.7 ± 3.9 0.61
Ninety-three patients (92.2%) did not have another 
seizure six months after the first seizure. Eight patients 
(7.8%) had recurrent seizures, of which four patients 
(3.9%) had seizures in the first four months. The other 
patients had their second seizure between 4–6 months 
of follow up. All of these 8 patients were in the placebo 
group (Figure 1). Analytical analysis shows a statistical 
significant difference in the recurrence rate between two 
groups (p = 0.04). 
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Discussion
Giving anti-epileptic drugs after the first seizure is 
controversial (18-23). In previous pediatric research, 
it was concluded that antiepileptic drugs diminish the 
chance of epilepsy recurrence; however, they have no 
role in the course of main management. Others endorse 
considering the likelihood of future attacks and the 
side effects of the drug before recommending them for 
first seizures (19, 20). Drugs with minimal side effects, 
good patient compliance, high effectiveness, and few 
contraindications are good choices for treatment. 
Phenytoin and barbiturates are unsuitable as they may 
cause some neurologic or psychological disorders. For 
focal seizures carbamazepine, clobazam (especially in 
pediatrics), gabapentin, carbamazepine, lamotrigine, 
topiramate, and valproate are recommended. The last 
three drugs are also used in the management of general 
seizures. 
First seizures may lead to future complications depending 
on the risk factors. The chief complaint of 0.2–0.3% 
of emergency room (ER) patients is first seizures (24, 
25). About 5% of the general population has at least 
experienced nonfebrile seizures in their lifetime (7, 
26). Therefore, it is necessary to have a protocol for the 
treatment of this condition. The administration of the 
antiepileptic drugs after first attack is still controversial. 
Those supporting the use of antiepileptic drugs 
emphasize the importance of recurrence and prognosis 
of the patients. Supporting this,  are researches that 
demonstrate that there is a 60–70% chance of recurrence 
after the first seizure in two years (15, 27-30). This 
rate is related to the primary etiology; if the cause is 
cerebral injury, head trauma, or other brain pathologies 
like tumors, then the risk of recurrence increases when 
compared to idiopathic seizures. Those against the use 
of the drugs are others who are concerned about the side 
effects of the drugs, especially on children. 
Musicco et al. prescribed carbamazepine, phenytoin, 
phenobarbital, or sodium valproate to treat the case group 
with first seizure and delayed treatment for controls. 
They showed that 24% of 215 patients in the case group 
and 42% of 204 patients in the control group experienced 
a second seizure. The most important predicting risk 
factors were age, benzodiazepine consumption, and 
an abnormal EEG. A total of 68% of patients treated 
with antiepileptic drugs immediately after first attack 
were symptom free in two years. Delayed treatment 
resulted in a higher recurrence rate (18). Marson et al. 
stated (19) that these statistically significant (p<0.05) 





Fig 1. Seizure recurrence rates in both groups (sodium valproate 200 mg three times a 
day and placebo group)
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